StonvexLoading…
StonvexCore line items from ALAR's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $40.76M | $31.82M | $26.52M | $18.55M |
Operating Income | $207.00K | $6.72M | $-5.50M | $-12.73M |
Net Income | $963.00K | $5.78M | $-5.53M | $-13.15M |
EPS (Diluted) | $0.01 | $0.08 | $-0.14 | $-0.42 |
Total Assets | $45.89M | $34.81M | $20.07M | $22.37M |
Total Liabilities | $13.80M | $8.46M | $6.88M | $9.06M |
Cash & Equivalents | $12.27M | $15.08M | $10.87M | $3.29M |
Free Cash Flow OCF − CapEx | $-2.16M | $8.79M | $4.57M | $-8.10M |
Shares Outstanding | 914.86K | 508.90K | 7.14M | 7.00M |